Search results
Author(s):
Paul Roberts
,
Mohamed Hassan ElRefai
,
Paul Foley
,
et al
Added:
1 year ago
Author(s):
Elise Bakelants
,
Haran Burri
Added:
2 years ago
Author(s):
Henry Chubb
,
Mark O’Neill
,
Eric Rosenthal
Added:
3 years ago
Device therapy is increasingly employed in the management of complex congenital heart disease (CHD). Bradycardias, most often related to sinus nodal dysfunction (SND) or atrioventricular nodal (AVN) block, may necessitate the implantation of pacing devices, while malignant arrhythmias may be treated by appropriate use of implantable cardioverter defibrillators (ICDs). However, there is a complex…
View more
Author(s):
Deepika Narasimha
,
Anne B Curtis
Added:
3 years ago
Implantable cardiac devices such as implantable cardioverter- defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices lead to improved survival and better clinical outcomes in appropriately selected patients with heart failure (HF) with a reduced ejection fraction (EF). Although there are significant sex differences in the aetiology, pathophysiology and clinical course of HF,…
View more
Author(s):
Pier D Lambiase
,
Joseph De Bono
,
Martin Lowe
,
et al
Added:
3 years ago
Heart rhythm consultants, primary care physicians, specialist registrars, nurses and physiologists may be requested to review ECGs or advise on cases where antipsychotic-induced QT prolongation is suspected or evident. The British Heart Rhythm Society has issued the Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication to support them…
View more
Author(s):
Haran Burri
Added:
3 years ago
Patients implanted with a pacemaker (PM) or implantable cardioverter defibrillator (ICD) require regular follow-ups to control the proper function of the implanted device. These technical checks have traditionally been performed manually in-office using a dedicated device programmer. In 1971, transtelephonic monitoring was introduced to remotely follow-up basic parameters (such as battery status…
View more
Author(s):
Niek EG Beurskens
,
Fleur VY Tjong
,
Reinoud Knops
Added:
3 years ago
Since its introduction in 2012, leadless pacemaker (LP) therapy has developed as a therapeutic alternative to conventional transvenous pacemaker (PM) therapy to circumvent lead- and pocket-related complications.1-4 To date, two LPs are available for patients with a single-chamber pacing (VVI) indication: the Nanostim Leadless Cardiac Pacemaker (LCP; Abbott) and the Micra Transcatheter Pacing…
View more
Author(s):
Ana Paula Tagliari
,
Adriano Nunes Kochi
,
Bernardo Mastella
,
et al
Added:
3 years ago
Cardiac implantable electronic devices (CIEDs), including permanent pacemakers (PPMs), ICD and CRT devices, are the mainstream therapy for many potentially lethal heart conditions, such as advanced atrioventricular block or sustained ventricular tachycardia or fibrillation. CIEDs can be implanted through endovascular or epicardial routes, with the former used the most because it is less invasive…
View more
Update in Cardiac Pacing
Author(s):
Nishant Verma
,
Bradley P Knight
Added:
3 years ago
Article
Author(s):
Manyoo A Agarwal
,
Aadhavi Sridharan
,
Rhea C Pimentel
,
et al
Added:
10 months ago